Security key
31189P102
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 101,146,307
- Share change
- +4,373,773
- Total reported value
- $3,918,572,903
- Put/Call ratio
- 59%
- Price per share
- $38.77
- Number of holders
- 235
- Value change
- +$154,288,770
- Number of buys
- 125
- Number of sells
- 102
Report period
Q1 2022
Institutions
235
Top holders
10
FATE full security history
Newer quarter: Q2 2022
Previous quarter: Q4 2021
FATE THERAPEUTICS INC SEC filings
FATE THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31189P102
Recent filing periods:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
|
Company |
11%
|
12,957,222
|
$758,127,000 | — | 31 Dec 2021 | |
| ARK Investment Management LLC |
13F
|
Company |
8.4%
|
10,312,167
|
$603,365,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.3%
|
7,675,787
|
$449,109,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.8%
|
7,060,552
|
$413,113,000 | — | 31 Dec 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.2%
|
3,933,938
|
$230,175,000 | — | 31 Dec 2021 | |
| Bellevue Group AG |
13F
|
Company |
3.1%
|
3,775,736
|
$220,918,000 | — | 31 Dec 2021 | |
| Casdin Capital, LLC |
13F
|
Company |
2.8%
|
3,400,000
|
$198,934,000 | — | 31 Dec 2021 | |
| JOHNSON & JOHNSON |
13F
|
Company |
2.8%
|
3,379,064
|
$197,709,000 | — | 31 Dec 2021 | |
| Capital World Investors |
13F
|
Company |
2.7%
|
3,259,033
|
$190,686,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
2,718,793
|
$159,077,000 | — | 31 Dec 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.6%
|
1,932,464
|
$113,069,000 | — | 31 Dec 2021 | |
| Artal Group S.A. |
13F
|
Company |
1.5%
|
1,800,000
|
$105,318,000 | — | 31 Dec 2021 | |
| FMR LLC |
13F
|
Company |
1.5%
|
1,777,329
|
$103,992,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
1,631,075
|
$95,435,000 | — | 31 Dec 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.3%
|
1,542,604
|
$90,259,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,425,968
|
$83,433,000 | — | 31 Dec 2021 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
1.2%
|
1,411,341
|
$82,578,000 | — | 31 Dec 2021 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
1%
|
1,242,843
|
$72,719,000 | — | 31 Dec 2021 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
1%
|
1,242,843
|
$72,209,000 | — | 31 Dec 2021 | |
| Grosvenor Holdings, L.L.C. |
13F
|
Company |
0.85%
|
1,037,256
|
$60,690,000 | — | 31 Dec 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.82%
|
998,491
|
$58,421,000 | — | 31 Dec 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.78%
|
955,312
|
$55,895,000 | — | 31 Dec 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.72%
|
883,279
|
$51,680,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.66%
|
812,107
|
$47,517,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.65%
|
794,708
|
$46,499,000 | — | 31 Dec 2021 | |
| NORGES BANK |
13F
|
Company |
0.65%
|
789,454
|
$46,191,000 | — | 31 Dec 2021 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.62%
|
757,425
|
$44,317,000 | — | 31 Dec 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.57%
|
699,752
|
$40,943,000 | — | 31 Dec 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.56%
|
683,372
|
$39,984,000 | — | 31 Dec 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.42%
|
511,652
|
$29,937,000 | — | 31 Dec 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
0.41%
|
500,000
|
$29,255,000 | — | 31 Dec 2021 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.39%
|
479,648
|
$28,064,000 | — | 31 Dec 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.37%
|
458,048
|
$26,800,000 | — | 31 Dec 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.35%
|
427,343
|
$25,003,838 | — | 31 Dec 2021 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.34%
|
420,190
|
$24,585,000 | — | 31 Dec 2021 | |
| Deep Track Capital, LP |
13F
|
Company |
0.34%
|
418,037
|
$24,459,000 | — | 31 Dec 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.34%
|
414,477
|
$24,254,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.33%
|
407,171
|
$23,824,000 | — | 31 Dec 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.31%
|
383,197
|
$22,422,000 | — | 31 Dec 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.3%
|
372,160
|
$21,775,000 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.29%
|
358,395
|
$20,970,000 | — | 31 Dec 2021 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.29%
|
352,336
|
$20,560,000 | — | 31 Dec 2021 | |
| Amundi |
13F
|
Individual |
0.31%
|
381,134
|
$16,084,000 | — | 31 Dec 2021 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.22%
|
274,829
|
$16,080,000 | — | 31 Dec 2021 | |
| Lombard Odier Asset Management (Switzerland) SA |
13F
|
Company |
0.22%
|
272,011
|
$15,915,000 | — | 31 Dec 2021 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
270,120
|
$15,805,000 | — | 31 Dec 2021 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.22%
|
270,000
|
$15,798,000 | — | 31 Dec 2021 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.22%
|
266,466
|
$15,591,000 | — | 31 Dec 2021 | |
| Eversept Partners, LP |
13F
|
Company |
0.21%
|
254,790
|
$14,907,763 | — | 31 Dec 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.21%
|
252,600
|
$14,780,000 | — | 31 Dec 2021 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q1 2022
As of 31 Mar 2022,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
235 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
101,146,307 shares.
The largest 10 holders included
Redmile Group, LLC, ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Capital World Investors, Bellevue Group AG, STATE STREET CORP, Casdin Capital, LLC, and JOHNSON & JOHNSON.
This page lists
236
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
240
Q1 2022 holders
235
Holder diff
-5
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.